Nor-Econ

Health economics in the treatment of inflammatory arthritis diseases

Project Manager
Gunnhild Hagen

Associate

Specialist in rheumatology | PhD

Sell Aarrestad Provan

ABOUT THE PROJECT

The REMEDY center will facilitate research that improves the treatment of patients with rheumatic and musculoskeletal disorders. To bridge the gap between clinical research and political decisions concerning the healthcare services, it is necessary to estimate the cost and effectiveness of treatments, and the burden of disease.

NOR-ECON is an inter-disciplinary project within work package 6. that aims to incorporate health- economic evaluations in ongoing REMEDY projects. NOR-ECON includes health-economic evaluations that are either part of randomised controlled trial (1), or within decision-making framework (2), but also analyses concerning health-related quality of life and costs from prospective studies and linkages to national register. The projects that are part of NOR-ECON thus utilise data from other studies. One example is the NOR-DMARD study. The NOR-DMARD is linked to several national registers including registers of social security and work participation. We can use this data to examine the cost of arthritic diseases.

Projects that we are working on:

1. We have performed health economic evaulations of NOR-DRUM and NOR-GOUT.

2. Several master students from the Department of Health Management and Health Economics (HELED) at the University of Oslo have written their thesis on health economic topics using data from NOR-ECON.